These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 217315)

  • 41. Absorption loss of peptides to the plastic tube in radioreceptor assay of calcitonin and beta-endorphin: protection by detergents.
    Koida M; Nakamuta H; Matsuo J; Yamamoto Y; Orlowski RC
    Jpn J Pharmacol; 1982 Jun; 32(3):413-8. PubMed ID: 6287068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of schizophrenia by hemosorption].
    Churkin EA; Gorbunova NA
    Klin Med (Mosk); 1985 Jan; 63(1):23-6. PubMed ID: 3157829
    [No Abstract]   [Full Text] [Related]  

  • 43. [Blood levels of beta-endorphins and the changes caused by neuroleptics in acute and chronic schizophrenics].
    Barcia D; Martínez A; López L; Ruiz ME; Galiana M; Muñoz R; Huertas F
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):3-10. PubMed ID: 6144248
    [No Abstract]   [Full Text] [Related]  

  • 44. Elevated opioid activity in sera of chronic schizophrenics.
    Idei M; Gróf J; Menyhárt J; Pajor A
    Acta Physiol Acad Sci Hung; 1982; 60(3):121-7. PubMed ID: 7185252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topography and characteristics of specific binding sites for non-opioid gamma-type endorphins in the rat brain as studied by autoradiography with [35S]Met-desenkephalin-gamma-endorphin.
    Ronken E; Wiegant VM; Kaspersen FM; van Nispen JW; de Boer T; Bruning HW; Rust CJ; Tonnaer JA
    Brain Res; 1993 Jun; 615(1):63-70. PubMed ID: 8395956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18.
    Vuolteenaho O
    Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodialysis in schizophrenia: psychiatric aspects of treatment failure in a pilot study.
    Rorsman B; Franzén G; Sjöstedt L; Lindholm T; Thysell H; Terenius L; Wahlström A
    Neuropsychobiology; 1981; 7(3):127-36. PubMed ID: 6112716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemodialysis in schizophrenia].
    Zvolský P; Schück O; Filip V; Martínek J
    Cas Lek Cesk; 1979 May; 118(18):563-5. PubMed ID: 455385
    [No Abstract]   [Full Text] [Related]  

  • 50. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of hemodialysis to diminish psychotic behavior in schizophrenia: behavioral and psychophysiological evaluation.
    van Kammen DP; Schulz SC; Balow JE; Zahn TP; Mundinger G; Flye MW; Bunney WE
    Artif Organs; 1983 Aug; 7(3):310-6. PubMed ID: 6312942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.
    Corbett AD; McKnight AT; Kosterlitz HW
    J Neurochem; 1988 Jul; 51(1):32-7. PubMed ID: 3379412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating opioid peptides in schizophrenia and depression.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840
    [No Abstract]   [Full Text] [Related]  

  • 54. Peptide E: opiate receptor binding profile in the rat brain membrane assay. Comparison with beta-endorphin.
    Westphal M; Li CH; Heimer EP; Meienhofer J
    Biochem Biophys Res Commun; 1983 Aug; 114(3):1084-8. PubMed ID: 6311195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of beta-endorphin in psychiatric patients.
    Berger PA; Barchas JD
    Ann N Y Acad Sci; 1982; 398():448-59. PubMed ID: 6297364
    [No Abstract]   [Full Text] [Related]  

  • 56. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Plasma concentration of immunoreactive beta-endorphin in healthy persons during pinpoint stimulation of receptors (acupuncture)].
    Szczudlik A; Lypka A
    Neurol Neurochir Pol; 1983; 17(5):535-40. PubMed ID: 6322035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endorphins in schizophrenia.
    van Ree JM; De Wied D
    Neuropharmacology; 1981 Dec; 20(12B):1271-7. PubMed ID: 6172743
    [No Abstract]   [Full Text] [Related]  

  • 59. Regional distribution of endorphin, Met5-enkephalin and Leu5-enkephalin in the pigeon brain.
    Bayon A; Koda L; Battenberg E; Azad R; Bloom FE
    Neurosci Lett; 1980 Jan; 16(1):75-80. PubMed ID: 6763159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation of [125I-Tyr27,Leu5]beta h-endorphin and its use for crosslinking of opioid binding sites in human striatum and NG108-15 neuroblastoma-glioma cells.
    Helmeste DM; Hammonds RG; Li CH
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4622-5. PubMed ID: 3014499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.